Literature DB >> 24709174

Surveillance of Mycoplasma pneumoniae infection among children in Beijing from 2007 to 2012.

Hanqing Zhao1, Shaoli Li1, Ling Cao2, Yi Yuan2, Guanhua Xue1, Yanling Feng1, Chao Yan1, Liqiong Wang1, Zhaoyang Fan3, Hongmei Sun4.   

Abstract

BACKGROUND: Mycoplasma pneumonia (M. pneumoniae) is one of the key pathogens of community-acquired pneumonia. A global pandemic of M. pneumoniae has occurred since 2010. The aim of this study was to survey the prevalence of M. pneumoniae in children in Beijing from 2007-2012.
METHODS: A total of 3 073 clinical specimens were obtained from pediatric patients with respiratory tract infections from January 2007 to December 2012, and examined by nested polymerase chain reaction. PCR products were visualized by 2% agarose gel electrophoresis, positive products sequenced, and compared with reference sequences in GenBank. Macrolide resistance-associated mutations were also detected for some positive samples.
RESULTS: Of the 3 073 specimens, 588 (19.13%) were positive for M. pneumoniae, 12.4% of which were accompanied by viral infections. Positive rates for M. pneumoniae were highest in 2007 and 2012, showing a significant difference when compared with other years. Infections tended to occur in autumn and winter and positive rates were significantly higher for children aged 3-16. The rate of macrolide resistance-associated mutations was 90.7%, and the predominant mutation was an A→G transition (89.92%) at position 2063 in domain V of the 23S rRNA gene.
CONCLUSIONS: M. pneumoniae outbreaks occurred in 2007 and 2012 in pediatric patients in Beijing, which is consistent with the global prevalence of M. pneumoniae. M. pneumoniae can cause multi-system infections in children, and may be accompanied with viral infections. We determined that school-age children are more susceptible to this disease, particularly in autumn and winter. Gene mutations associated with macrolide resistance were very common in M. pneumoniae-positive specimens during this period in Beijing.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24709174

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  11 in total

1.  Changes in the Levels of Interleukin-17 Between Atopic and Non-atopic Children with Mycoplasma pneumoniae Pneumonia.

Authors:  Zhi-Hua Wang; Xin-Min Li; Yu-Shui Wang; Ze-Yang Guo
Journal:  Inflammation       Date:  2016-12       Impact factor: 4.092

2.  The Prevalence of Mycoplasma Pneumoniae Among Children in Beijing Before and During the COVID-19 Pandemic.

Authors:  Yuan Cheng; Yijing Cheng; Shuzhi Dai; Dongqing Hou; Menglei Ge; Yi Zhang; Lei Fan; Yingying Pei; Li Yu; Guanhua Xue; Lijuan Ma; Hongmei Sun
Journal:  Front Cell Infect Microbiol       Date:  2022-04-29       Impact factor: 6.073

3.  Analysis of mycoplasma pneumoniae infection among children with respiratory tract infections in hospital in Chengdu from 2014 to 2020.

Authors:  Lei Zhang; Meimei Lai; Tao Ai; Huiling Liao; Yijie Huang; Ying Zhang; Yanru Liu; Li Wang; Jie Hu
Journal:  Transl Pediatr       Date:  2021-04

Review 4.  Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae.

Authors:  Tsutomu Yamazaki; Tsuyoshi Kenri
Journal:  Front Microbiol       Date:  2016-05-23       Impact factor: 5.640

5.  The Protective Effect of Naringenin on Airway Remodeling after Mycoplasma Pneumoniae Infection by Inhibiting Autophagy-Mediated Lung Inflammation and Fibrosis.

Authors:  Yan Lin; Dan Tan; Qianna Kan; Zhen Xiao; Zhiyan Jiang
Journal:  Mediators Inflamm       Date:  2018-04-04       Impact factor: 4.711

6.  Comparison of the molecular characteristics of Mycoplasma pneumoniae from children across different regions of China.

Authors:  Guanhua Xue; Ming Li; Na Wang; Jing Zhao; Bei Wang; Zhimin Ren; Chao Yan; Chengqing Wu; Yang Liu; He Sun; Min Xu; Hongmei Sun
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

7.  Antimicrobial susceptibility and genotyping of Mycoplasma pneumoniae isolates in Beijing, China, from 2014 to 2016.

Authors:  Fei Zhao; Jinrong Liu; Weixian Shi; Fang Huang; Liyong Liu; Shunying Zhao; Jianzhong Zhang
Journal:  Antimicrob Resist Infect Control       Date:  2019-01-24       Impact factor: 4.887

Review 8.  A Compendium for Mycoplasma pneumoniae.

Authors:  Gretchen L Parrott; Takeshi Kinjo; Jiro Fujita
Journal:  Front Microbiol       Date:  2016-04-12       Impact factor: 5.640

9.  Pediatric clinical features of Mycoplasma pneumoniae infection are associated with bacterial P1 genotype.

Authors:  Liping Fan; Dong Li; Liqiong Zhang; Chuangli Hao; Huiquan Sun; Xuejun Shao; Jun Xu; Zhengrong Chen
Journal:  Exp Ther Med       Date:  2017-07-09       Impact factor: 2.447

10.  Periodic Genotype Shifts in Clinically Prevalent Mycoplasma pneumoniae Strains in Japan.

Authors:  Tsuyoshi Kenri; Masato Suzuki; Tsuyoshi Sekizuka; Hitomi Ohya; Yoichiro Oda; Tsutomu Yamazaki; Hiroyuki Fujii; Toru Hashimoto; Hiroshi Nakajima; Chihiro Katsukawa; Makoto Kuroda; Keigo Shibayama
Journal:  Front Cell Infect Microbiol       Date:  2020-08-06       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.